PCM
RMD icon

Prelude Capital Management’s ResMed RMD Stock Holding History

Prelude Capital Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,095
Closed -$246K – 1489
2026
Q1 		$246K Buy
+1,095
New +$273K 0.02% 808
2025
Q2 		– Sell
-1,671
Closed -$374K – 1300
2025
Q1 		$374K Buy
1,671
+28
+2% +$6.54K 0.03% 611
2024
Q4 		$376K Buy
+1,643
New +$396K 0.02% 701
2024
Q3 		– Sell
-3,145
Closed -$602K – 1501
2024
Q2 		$602K Sell
3,145
-5
-0.2% -$1.01K 0.04% 463
2024
Q1 		$624K Buy
3,150
+1,385
+78% +$254K 0.03% 538
2023
Q4 		$304K Sell
1,765
-620
-26% -$95.3K 0.02% 733
2023
Q3 		$353K Sell
2,385
-143
-6% -$25.9K 0.02% 595
2023
Q2 		$552K Buy
+2,528
New +$563K 0.04% 430
2022
Q1 		– Sell
-1,366
Closed -$356K – 2164
2021
Q4 		$356K Buy
1,366
+102
+8% +$26.5K 0.01% 1220
2021
Q3 		$333K Buy
1,264
+283
+29% +$77.4K 0.01% 1087
2021
Q2 		$242K Sell
981
-2,639
-73% -$555K 0.01% 1304
2021
Q1 		$702K Buy
+3,620
New +$726K 0.02% 753
2020
Q4 		– Sell
-367
Closed -$63K – 1875
2020
Q3 		$63K Buy
+367
New +$67.8K ﹤0.01% 1060
2016
Q2 		– Sell
-1,122
Closed -$65K – 1713
2016
Q1 		$65K Buy
+1,122
New +$63.5K 0.01% 898
2014
Q1 		– Sell
-2,700
Closed -$127K – 2072
2013
Q4 		$127K Sell
2,700
-1,699
-39% -$86K 0.02% 778
2013
Q3 		$232K Buy
+4,399
New +$213K 0.04% 497

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Prelude Capital Management's RMD Position: Q2 2026 in Review

Prelude Capital Management sold out of ResMed (RMD) in Q2 2026, closing a stake of 1,095 shares — an estimated $246K sold.

Prelude Capital Management first reported a position in RMD in Q3 2013 and held it in 16 quarters. The position peaked at $702K in Q1 2021. 889 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Prelude Capital Management reported no remaining ResMed position as of Q2 2026 after selling out during the quarter.
  • Prelude Capital Management sold 1,095 ResMed shares in Q2 2026, an estimated $246K.
  • Prelude Capital Management first reported a position in ResMed in Q3 2013 and held it in 16 quarters.
  • Prelude Capital Management's ResMed position peaked at $702K in Q1 2021.
  • 889 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Prelude Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.